About: Characteristics and Outcomes in Patients Presenting with COVID-19 and ST-Segment Elevation Myocardial Infarction

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Characteristics and Outcomes in Patients Presenting with COVID-19 and ST-Segment Elevation Myocardial Infarction Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Characteristics and Outcomes in Patients Presenting with COVID-19 and ST-Segment Elevation Myocardial Infarction
Creator	Al Dujeili, Montazar Al, Montazar Al-Kafeel, Al-Obeidi, Ammar Aldujeli, Ali Briedis, Kasparas Hamadeh, Anas Karbala, Luís, Jose Mccullough, Peter Sanz Sánchez, Jorge Stoler, Robert Tecson, Kristen
Source	Elsevier; Medline; PMC
abstract	There is limited information regarding clinical characteristics and outcomes of patients with SARS-CoV-2 (COVID-19) disease presenting with ST-segment elevation myocardial infarction (STEMI). In this multicenter retrospective study, we reviewed charts of patients admitted with symptomatic COVID-19 infection and STEMI to a total of 4 hospitals spanning Italy, Lithuania, Spain and Iraq from February 1, 2020 to April 15, 2020. A total of 78 patients were included in this study, 49 (63%) of whom were men, with a median age of 65 [58, 71] years, and high comorbidity burden. During hospitalization, 8 (10%) developed acute respiratory distress syndrome, and 14 (18%) required mechanical ventilation. 19 (24%) patients were treated with primary PCI and 59 (76%) were treated with fibrinolytic therapy. 13 (17%) patients required cardiac resuscitation, and 9 (11%) died. For the 19 patients treated with primary PCI, 8 (42%) required intubation and 8 (42%) required cardiac resuscitation; stent thrombosis occurred in 4 patients (21%). A total of 5 patients (26%) died during hospitalization. 50 (85%) of the 59 patients initially treated with fibrinolytic therapy had successful fibrinolysis. The median time to reperfusion was 27 minutes [20, 34]. Hemorrhagic stroke occurred in 5 patients (9%). Six patients (10%) required invasive mechanical ventilation; 5 (9%) required cardiac resuscitation, and 4 (7%) died. In conclusion, this is the largest case series to-date of COVID-19 positive patients presenting with STEMI and spans 4 countries. We found a high rate of stent thrombosis, indicating a possible need to adapt STEMI management for COVID-19 patients.
has issue date	2020-07-03(xsd:dateTime)
bibo:doi	10.1016/j.amjcard.2020.06.063
bibo:pmid	32732010
has license	no-cc
sha1sum (hex)	92205b253d59235effe41e15f028c7109fe813dd
schema:url	https://doi.org/10.1016/j.amjcard.2020.06.063
resource representing a document's title	Characteristics and Outcomes in Patients Presenting with COVID-19 and ST-Segment Elevation Myocardial Infarction
has PubMed Central identifier	PMC7333635
has PubMed identifier	32732010
schema:publication	Am J Cardiol
resource representing a document's body	covid:92205b253d59235effe41e15f028c7109fe813dd#body_text
is schema:about of	named entity 'patients' named entity 'STEMI' named entity 'COVID-19' named entity 'SARS-CoV-2' named entity 'Presenting' named entity 'ACUTE RESPIRATORY DISTRESS SYNDROME' named entity 'POSSIBLE' named entity 'OCCURRED' named entity 'SEGMENT' named entity 'COVID-19' named entity 'study' named entity 'spans' named entity 'hospitalization' named entity 'COVID-19' named entity 'patients' named entity 'comorbidity' named entity 'hospitalization' named entity 'During' named entity 'Italy' named entity 'retrospective study' named entity 'STEMI' named entity 'high' named entity 'thrombosis' named entity 'patients' named entity 'patients' named entity 'spanning' named entity 'Italy' named entity 'STEMI' named entity 'cardiac resuscitation' named entity 'Lithuania' named entity 'cardiac resuscitation' named entity 'primary PCI' named entity 'acute respiratory distress syndrome' named entity 'STEMI' named entity 'mechanical ventilation' named entity 'COVID' named entity 'thrombosis' named entity 'STEMI' named entity 'COVID-19' named entity 'patients' named entity 'COVID' named entity 'infarcted' named entity 'primary PCI' named entity 'myocardial infarction' named entity 'medical doctors' named entity 'acute respiratory distress syndrome' named entity 'COVID' named entity 'fibrinolytics' named entity 'clinical characteristics' named entity 'Lithuania' named entity 'chest pain' named entity 'ST segment' named entity 'hemodynamic' named entity 'case series' named entity 'symptom' named entity 'COVID' named entity 'Iraq' named entity 'hypertension' named entity 'reperfusion' named entity 'angina' named entity 'COVID' named entity 'pathophysiologic' named entity 'fibrinolytic therapy' named entity 'Iraq' named entity 'echocardiography' named entity 'COVID' named entity 'cardiac resuscitation' named entity 'thrombotic events' named entity 'PCI'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software